...
首页> 外文期刊>Microarrays >Unraveling the Specific Ischemic Core and Penumbra Transcriptome in the Permanent Middle Cerebral Artery Occlusion Mouse Model Brain Treated with the Neuropeptide PACAP38
【24h】

Unraveling the Specific Ischemic Core and Penumbra Transcriptome in the Permanent Middle Cerebral Artery Occlusion Mouse Model Brain Treated with the Neuropeptide PACAP38

机译:在用神经肽PACAP38治疗的永久性中脑动脉阻塞小鼠模型大脑中揭示特定的缺血核心和半影转录组

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Our group has been systematically investigating the effects of the neuropeptide pituitary adenylate-cyclase activating polypeptide (PACAP) on the ischemic brain. To do so, we have established and utilized the permanent middle cerebral artery occlusion (PMCAO) mouse model, in which PACAP38 (1 pmol) injection is given intracerebroventrically and compared to a control saline (0.9% sodium chloride, NaCl) injection, to unravel genome-wide gene expression changes using a high-throughput DNA microarray analysis approach. In our previous studies, we have accumulated a large volume of data (gene inventory) from the whole brain (ipsilateral and contralateral hemispheres) after both PMCAO and post-PACAP38 injection. In our latest research, we have targeted specifically infarct or ischemic core (hereafter abbreviated IC) and penumbra (hereafter abbreviated P) post-PACAP38 injections in order to re-examine the transcriptome at 6 and 24 h post injection. The current study aims to delineate the specificity of expression and localization of differentially expressed molecular factors influenced by PACAP38 in the IC and P regions. Utilizing the mouse 4 × 44 K whole genome DNA chip we show numerous changes (≧/≦ 1.5/0.75-fold) at both 6 h (654 and 456, and 522 and 449 up- and down-regulated genes for IC and P, respectively) and 24 h (2568 and 2684, and 1947 and 1592 up- and down-regulated genes for IC and P, respectively) after PACAP38 treatment. Among the gene inventories obtained here, two genes, brain-derived neurotrophic factor (Bdnf) and transthyretin (Ttr) were found to be induced by PACAP38 treatment, which we had not been able to identify previously using the whole hemisphere transcriptome analysis. Using bioinformatics analysis by pathway- or specific-disease-state focused gene classifications and Ingenuity Pathway Analysis (IPA) the differentially expressed genes are functionally classified and discussed. Among these, we specifically discuss some novel and previously identified genes, such as alpha hemoglobin stabilizing protein (Ahsp), cathelicidin antimicrobial peptide (Camp), chemokines, interferon beta 1 (Ifnb1), and interleukin 6 (Il6) in context of PACAP38-mediated neuroprotection in the ischemic brain. Taken together, the DNA microarray analysis provides not only a great resource for further study, but also reinforces the importance of region-specific analyses in genome-wide identification of target molecular factors that might play a role in the neuroprotective function of PACAP38.
机译:我们的小组一直在系统地研究神经肽垂体腺苷酸环化酶激活多肽(PACAP)对缺血性脑的影响。为此,我们建立并利用了永久性大脑中动脉闭塞(PMCAO)小鼠模型,其中脑室内给予PACAP38(1 pmol)注射,并与对照盐水(0.9%氯化钠,NaCl)注射进行比较使用高通量DNA微阵列分析方法,可进行全基因组范围内的基因表达变化。在我们以前的研究中,我们在PMCAO和PACAP38注射后从全脑(同侧和对侧半球)积累了大量数据(基因清单)。在我们的最新研究中,我们针对PACAP38注射后的特异性梗塞或缺血性核心(以下简称IC)和半影(以下简称P),以便在注射后6和24小时重新检查转录组。当前的研究旨在描述受PACAP38影响的IC和P区差异表达分子因子的表达和定位特异性。利用小鼠4×44 K全基因组DNA芯片,我们在6小时内(654和456,以及522和449上调和下调IC和P的基因)显示出许多变化(≥/≦1.5 / 0.75倍), PACAP38处理后分别为24小时(分别为2568和2684,以及1947和1592分别为IC和P上调和下调的基因)。在这里获得的基因清单中,发现两个基因,即脑源性神经营养因子(Bdnf)和运甲状腺素蛋白(Ttr)是由PACAP38处理诱导的,我们以前无法使用整个半球转录组分析来鉴定。使用通过途径或特定疾病状态聚焦的基因分类和独创性途径分析(IPA)的生物信息学分析,对差异表达的基因进行功能分类和讨论。在这些当中,我们专门讨论了一些新的和先前鉴定的基因,例如在PACAP38-介导的缺血性脑神经保护作用。综上所述,DNA微阵列分析不仅为进一步研究提供了重要资源,而且还增强了区域特异性分析在全基因组范围内鉴定可能在PACAP38的神经保护功能中起作用的靶分子因子的重要性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号